UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 20, pp. 1946 - 1960
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Induction Chemotherapy | Male | Remission Induction | Ustekinumab - therapeutic use | Ustekinumab - adverse effects | Ustekinumab - pharmacokinetics | Crohn Disease - drug therapy | Ustekinumab - immunology | Adult | Female | Maintenance Chemotherapy | Infusions, Intravenous | Intravenous administration | Cytokines | Body weight | Clinical trials | Interleukin 23 | Interleukin 12 | Antagonists | Patients | Crohns disease | Side effects | Tumor necrosis factor | Immunotherapy | Monoclonal antibodies | Tumor necrosis factor-TNF | Remission | Index Medicus | Abridged Index Medicus
Journal Article
American journal of hematology, ISSN 0361-8609, 02/2019, Volume 94, Issue 2, pp. 209 - 215
Journal Article
Annals of internal medicine, ISSN 0003-4819, 2007, Volume 146, Issue 12, pp. 829 - 838
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Prospective Studies | Double-Blind Method | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Remission Induction | Crohn Disease - complications | Antibodies, Monoclonal, Humanized | Infliximab | Crohn Disease - drug therapy | Treatment Failure | Adolescent | Adult | Female | Aged | Adalimumab | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Crohn's disease | Drug therapy | Health aspects | Clinical trials | Antagonist drugs | Clinical outcomes | Crohns disease | Index Medicus | Abridged Index Medicus
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 05/2016, Volume 43, Issue 10, pp. 1090 - 1102
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Crohn Disease - epidemiology | Antibodies, Monoclonal, Humanized - therapeutic use | Leukocyte L1 Antigen Complex - analysis | Prospective Studies | Humans | Male | Colitis, Ulcerative - epidemiology | Remission Induction | Tumor Necrosis Factor-alpha - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Smoking - epidemiology | Crohn Disease - drug therapy | Adult | Female | Colitis, Ulcerative - drug therapy | Germany | Cohort Studies | Medicine, Experimental | Medical research | Care and treatment | Immunoglobulin G | Ulcerative colitis | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 01/2015, Volume 162, Issue 1, pp. 18 - 26
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glucocorticoids - therapeutic use | Prospective Studies | Kidney - pathology | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Lupus Nephritis - drug therapy | Male | Methylprednisolone - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Adult | Female | Drug Therapy, Combination | Glucocorticoids - adverse effects | Lupus Nephritis - pathology | Prednisone - adverse effects | Tacrolimus - adverse effects | Remission Induction | Mycophenolic Acid - adverse effects | Tacrolimus - therapeutic use | Pilot Projects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Biopsy | Adolescent | Immunosuppressive Agents - adverse effects | Aged | Prednisone - therapeutic use | Lupus | Complications and side effects | Drug targeting | Nephritis | Drug therapy | Methods | Drugs | Clinical trials | Kidney diseases | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10080, pp. 1699 - 1709
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Interleukin-23 Subunit p19 - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Remission Induction | Dose-Response Relationship, Drug | Young Adult | Antibodies, Monoclonal - administration & dosage | Crohn Disease - drug therapy | Adolescent | Gastrointestinal Agents - therapeutic use | Adult | Female | Aged | Gastrointestinal Agents - adverse effects | Clinical trials | Monoclonal antibodies | Medicine, Experimental | Medical research | Interleukins | Intravenous administration | Pathogenesis | Mucosa | Interleukin | Interleukin 23 | Antagonists | Evidence-based medicine | Intravenous therapy | Randomization | Endoscopes | Motivation | Gastroenterology | Remission | Tumor necrosis factor-TNF | Colon | Safety | Active control | Chronic illnesses | Psoriasis | Cytokines | Ileitis | Nausea | Inflammation | Crohn's disease | Disease control | Patients | Ileum | Crohns disease | Inflammatory bowel disease | Interactive systems | Tumor necrosis factor | Ulcers | TNF inhibitors | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1723 - 1736
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Protein Kinase Inhibitors - pharmacokinetics | Pyrroles - pharmacokinetics | Double-Blind Method | Humans | Middle Aged | Induction Chemotherapy | Male | Protein Kinase Inhibitors - adverse effects | Chi-Square Distribution | Remission Induction | Janus Kinases - antagonists & inhibitors | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Pyrroles - adverse effects | Adult | Female | Piperidines - pharmacokinetics | Maintenance Chemotherapy | Colitis, Ulcerative - drug therapy | Pyrroles - therapeutic use | Treatment outcome | Tofacitinib | Patient outcomes | Analysis | Dosage and administration | Drug therapy | Ulcerative colitis | Inflammatory bowel disease | Studies | Colon | Gastroenterology | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 5, pp. 490 - 497
Life Sciences & Biomedicine | Oncology | Science & Technology | Oropharyngeal Neoplasms - therapy | Radiotherapy Dosage | Chemoradiotherapy - adverse effects | Papillomavirus Infections - complications | Human papillomavirus 16 - physiology | Drug Administration Schedule | Humans | Middle Aged | Induction Chemotherapy - methods | Carcinoma, Squamous Cell - therapy | Male | Remission Induction | Oropharyngeal Neoplasms - complications | Exanthema - etiology | Neutropenia - etiology | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Squamous Cell - complications | Adult | Cetuximab - administration & dosage | Female | Papillomavirus Infections - virology | Aged | Index Medicus | Chemotherapy | Combined Modality | ORIGINAL REPORTS | Radiation
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 711 - 721
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | General aspects | Medical sciences | Other diseases. Semiology | Antibodies, Monoclonal, Humanized - adverse effects | Glucocorticoids - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Integrins - immunology | Middle Aged | Induction Chemotherapy | Male | Crohn Disease - drug therapy | Infusions, Intravenous - adverse effects | Adult | Antibodies - blood | Female | Maintenance Chemotherapy | Antibodies, Monoclonal, Humanized - immunology | Drug Therapy, Combination | Integrins - antagonists & inhibitors | Monoclonal antibodies | Crohn's disease | Research | Drug therapy | Inflammatory bowel disease | Headache | Medical research | Pain | Intravenous administration | Ulcers | Clinical trials | Remission | Rhinopharyngitis | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article